DeepMed Research

HENRY FORD HEALTH SYSTEM

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1915-01-01

Employees: 5K

Market Cap: -

Website: http://www.henryford.com

Clinical Trials

Subscapularis Strength After Total Shoulder Arthroplasty

Not Applicable

Completed

Conditions: Shoulder Osteoarthritis

Interventions: Procedure: Subscapularis Rehabilitation
Procedure: Standard Rehabilitation

First Posted Date: 2019-02-26

Last Posted Date: 2022-11-04

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 66

Registration Number: NCT03854357

Locations: 🇺🇸
Henry Ford Health Systems, Detroit, Michigan, United States

Immuno-regulatory Profiling of T Cells in GVHD Treated With Extracorporeal Photopheresis

Completed

Conditions: GVHD

Interventions: Other: blood samples

First Posted Date: 2019-02-22

Last Posted Date: 2023-10-26

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 6

Registration Number: NCT03851601

Locations: 🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States

Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant

Phase 2

Active, not recruiting

Conditions: Prophylaxis
Stem Cell Transplant Complications

Interventions: Drug: Levofloxacin
Drug: Ciprofloxacin

First Posted Date: 2019-02-21

Last Posted Date: 2024-04-23

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 308

Registration Number: NCT03850379

Locations: 🇺🇸
Henry Ford, Detroit, Michigan, United States

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib

Phase 2

Recruiting

Conditions: Hematological Malignancy

Interventions: Drug: Bortezomib

First Posted Date: 2019-02-21

Last Posted Date: 2025-02-11

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 15

Registration Number: NCT03850366

Locations: 🇺🇸
Henry Ford hospital, Detroit, Michigan, United States

Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

Phase 2

Recruiting

Conditions: Myeloid Malignancy

Interventions: Drug: azacitidine

First Posted Date: 2019-02-21

Last Posted Date: 2025-02-10

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 43

Registration Number: NCT03850418

Locations: 🇺🇸
Henry ford hospital, Detroit, Michigan, United States

Nonopioid Analgesia After Labral Surgery

Phase 2

Recruiting

Conditions: Narcotic Use

Interventions: Drug: Hydrocodone-Acetaminophen
Drug: Celecoxib
Drug: Ketorolac
Drug: Gabapentin
Drug: Acetaminophen
Drug: Diazepam

First Posted Date: 2019-01-31

Last Posted Date: 2019-01-31

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 100

Registration Number: NCT03825809

Locations: 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States

Nonopioid Analgesia After Arthroscopic Meniscus Surgery

Early Phase 1

Completed

Conditions: Meniscus Disorder
Narcotic Use

Interventions: Drug: Hydrocodon/Acetaminophen
Drug: Celecoxib
Drug: Ketorolac
Drug: Gabapentin
Drug: Acetaminophen
Drug: Diazepam

First Posted Date: 2019-01-29

Last Posted Date: 2023-12-05

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 61

Registration Number: NCT03820193

Locations: 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States

Nonopioid Analgesia After Rotator Cuff Repair

Phase 2

Completed

Conditions: Rotator Cuff Tear

Interventions: Drug: Hydrocodone-Acetaminophen
Drug: Celecoxib
Drug: Ketorolac
Drug: Gabapentin
Drug: Acetaminophen
Drug: Diazepam

First Posted Date: 2019-01-28

Last Posted Date: 2024-04-02

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 70

Registration Number: NCT03818919

Locations: 🇺🇸
Health Ford Health System, Detroit, Michigan, United States

Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction

Phase 2

Completed

Conditions: Anterior Cruciate Ligament Injury

Interventions: Drug: Hydrocodone-Acetaminophen
Drug: Celecoxib
Drug: Ketorolac
Drug: Gabapentin
Drug: Acetaminophen
Drug: Diazepam

First Posted Date: 2019-01-28

Last Posted Date: 2021-02-11

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 62

Registration Number: NCT03818932

Locations: 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States

Hepatic Vein Flow During Orthotopic Liver Transplantation as Predictive Factor for Postoperative Graft Function

Completed

Conditions: Postoperative Graft Function

Interventions: Other: NO internvention

First Posted Date: 2019-01-23

Last Posted Date: 2020-11-04

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 97

Registration Number: NCT03814031

Locations: 🇺🇸
HFHS, Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy